UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications

The pharmacogenomics journal, 2021-04, Vol.21 (2), p.190-199

Biswas, Mohitosh

2021

Link zum Volltext

Verfügbarkeit prüfen

Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review

PloS one, 2022-03, Vol.17 (3), p.e0265496-e0265496

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis

Cardiovascular drugs and therapy, 2021-12, Vol.35 (6), p.1147-1159

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis

Scientific reports, 2021-03, Vol.11 (1), p.5012-5012, Article 5012

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis

International journal of clinical pharmacy, 2021-10, Vol.43 (5), p.1360-1369

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis

Platelets (Edinburgh), 2021-07, Vol.32 (5), p.591-600

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications

Frontiers in pharmacology, 2024-02, Vol.14, p.1285967-1285967

2024

Link zum Volltext

Verfügbarkeit prüfen

In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh

BMC research notes, 2015-10, Vol.8 (623), p.621-621, Article 621

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

Frontiers in pharmacology, 2022-02, Vol.13, p.835136-835136

2022

Link zum Volltext

Verfügbarkeit prüfen

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis

Clinical and translational science, 2022-08, Vol.15 (8), p.1887-1905

2022

Link zum Volltext

Verfügbarkeit prüfen

Potential clinically significant life-threatening drug–drug interactions of lopinavir and ritonavir used in the treatment of COVID-19

Experimental Results, 2020, Vol.1, Article e49

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patients

Pharmacogenomics, 2021-04, Vol.22 (6), p.375-381

Biswas, Mohitosh

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients

Pharmacogenomics, 2021-04

Biswas, Mohitosh

2021

Link zum Volltext

Verfügbarkeit prüfen

The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta‐analysis

Clinical and translational science, 2024-04, Vol.17 (4), p.e13792-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of UGT1A16, UGT1A128, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis

Clinical and translational science, 2022-07, Vol.15 (7), p.1613-1633

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

BMC medical genomics, 2024-04, Vol.17 (1), p.101-101, Article 101

2024

Link zum Volltext

Verfügbarkeit prüfen

S71GENETIC VARIABILITY OF CYP2C19 IN THE WORLD POPULATION AFFECTING SAFETY AND EFFICACY OF PSYCHIATRIC MEDICATIONS

European neuropsychopharmacology, 2019-10, Vol.29, p.S150-S150

Biswas, Mohitosh

2019

Link zum Volltext

Verfügbarkeit prüfen

Implementation of HLA-B15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand

Frontiers in pharmacology, 2022-07, Vol.13, p.867490-867490

2022

Link zum Volltext

Verfügbarkeit prüfen

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

Frontiers in pharmacology, 2022-04, Vol.13, p.866903-866903

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications

Pharmacogenomics, 2023-10, Vol.24 (15), p.831-840

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians

Pharmaceutics, 2022-02, Vol.14 (2), p.401

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

Intervirology, 2021-01, Vol.64 (1), p.36-47

2021

Link zum Volltext

Verfügbarkeit prüfen

Prescription antibiotics for outpatients in Bangladesh: a cross-sectional health survey conducted in three cities

Annals of clinical microbiology and antimicrobials, 2014-04, Vol.13 (1), p.15-15

2014

Link zum Volltext

Verfügbarkeit prüfen

Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19

International journal of clinical practice (Esher), 2021-11, Vol.75 (11), p.e14710-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenomics in Asians: Differences and similarities with other human populations

Expert opinion on drug metabolism & toxicology, 2023-01, Vol.19 (1), p.27-41

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications

Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review

Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis

Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis

Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis

Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications

In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis

Potential clinically significant life-threatening drug–drug interactions of lopinavir and ritonavir used in the treatment of COVID-19

Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in COVID-19 patients

Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients

The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta‐analysis

Association of UGT1A16, UGT1A128, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis

Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

S71GENETIC VARIABILITY OF CYP2C19 IN THE WORLD POPULATION AFFECTING SAFETY AND EFFICACY OF PSYCHIATRIC MEDICATIONS

Implementation of HLA-B15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications

Effect of GSTA1 Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians

Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

Prescription antibiotics for outpatients in Bangladesh: a cross-sectional health survey conducted in three cities

Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19

Pharmacogenomics in Asians: Differences and similarities with other human populations

Suchergebnisse filtern